Lista de obras - Brit Mollenhauer - Dominio Público Uruguay

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

artículo científico publicado en 2016

A Practical Guide to Immunoassay Method Validation

artículo científico publicado en 2015

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

artículo científico publicado en 2011

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

artículo científico publicado en 2017

Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort.

artículo científico publicado en 2017

Affective and cognitive Theory of Mind in patients with parkinson's disease

artículo científico publicado en 2010

Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?

artículo científico publicado en 2012

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

artículo científico publicado en 2016

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

artículo científico publicado en 2016

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study

artículo científico publicado en 2018

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease

artículo científico publicado en 2016

Associated factors for REM sleep behavior disorder in Parkinson disease

artículo científico publicado en 2011

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

artículo científico publicado en 2013

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease

artículo científico publicado en 2015

Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.

artículo científico publicado en 2017

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort

artículo científico publicado en 2017

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

artículo científico publicado en 2003

Biobanking of CSF: international standardization to optimize biomarker development

artículo científico

Biochemical premotor biomarkers for Parkinson's disease

artículo científico publicado en 2012

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

artículo científico

Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.

artículo científico publicado en 2010

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Biomarkers in biological fluids for dementia with Lewy bodies

artículo científico publicado en 2014

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

artículo científico publicado en 2007

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

artículo científico publicado en 2006

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.

artículo científico publicado en 2011

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

artículo científico publicado en 2016

CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies

artículo científico publicado en 2010

Can we prevent and slow down neurodegeneration with diet and exercise?

artículo científico publicado en 2015

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease

artículo científico

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

artículo científico publicado en 2016

Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease

artículo científico

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

artículo científico publicado en 2014

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

artículo científico publicado en 2008

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

artículo científico publicado en 2010

Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease

artículo científico publicado en 2008

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

artículo científico publicado en 2016

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

artículo científico publicado en 2013

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study

scientific article published on 19 February 2020

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

artículo científico publicado en 2017

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia

artículo científico publicado en 2010

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

artículo científico publicado en 2009

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

artículo científico publicado en 2016

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder

artículo científico publicado en 2020

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease

artículo científico publicado en 2017

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

artículo científico publicado en 2012

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

artículo científico publicado en 2016

Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid

artículo científico

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

artículo científico publicado en 2017

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

artículo científico publicado en 2012

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits

artículo científico publicado en 2015

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

artículo científico publicado en 2008

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.

artículo científico publicado en 2017

Erratum to: Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease

scholarly article published in Journal of Neural Transmission

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

artículo científico publicado en 2016

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation

artículo científico publicado en 2015

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)

scholarly article by Lana M Chahine et al published 2018 in Journal of Parkinson's disease

Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies

scientific article published on 12 February 2020

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

artículo científico publicado en 2005

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

artículo científico publicado en 2008

GBA variants in REM sleep behavior disorder: a multicenter study

artículo científico publicado en 2020

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

artículo científico publicado en 2004

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

artículo científico publicado en 2014

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)

Improved preparation of nasal lavage fluid (NLF) as a noninvasive sample for proteomic biomarker discovery

artículo científico publicado en 2015

Increased CSF biomarkers of angiogenesis in Parkinson disease.

artículo científico publicado en 2016

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies

artículo científico publicado en 2015

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.

artículo científico publicado en 2011

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

artículo científico publicado en 2018

Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions

artículo científico publicado en 2010

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

artículo científico publicado en 2017

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.

artículo científico publicado en 2018

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

artículo científico publicado en 2011

Metabolic profiling of body fluids and multivariate data analysis

artículo científico publicado en 2017

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

artículo científico publicado en 2015

MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity

artículo científico publicado en 2012

Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress

artículo científico publicado en 2016

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

artículo científico publicado en 2016

Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration

artículo científico publicado en 2016

Mutations in VPS26A are not a frequent cause of Parkinson's disease.

artículo científico publicado en 2013

Neurochemical biomarkers in the differential diagnosis of movement disorders

artículo científico publicado en 2009

Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders

artículo científico publicado en 2013

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

scholarly article by Franziska Hopfner et al published 2019 in Translational Neurodegeneration

Non-Motor Correlates of Smoking Habits in de Novo Parkinson's Disease

artículo científico publicado en 2015

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

artículo científico publicado en 2013

Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease

artículo científico publicado en 2005

Novel Associations of <i>BST1</i> and <i>LAMP3</i> with Rapid Eye Movement Sleep Behavior Disorder

artículo científico publicado en 2021

Novel one-step immunoassays to quantify α-synuclein: applications for biomarker development and high-throughput screening

artículo científico publicado en 2012

Parkinson's disease biomarkers based on α-synuclein

artículo científico publicado en 2019

Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)

scholarly article by Monika Balzer-Geldsetzer et al published 2011 in Neuroepidemiology

Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy

artículo científico publicado en 2008

Prediagnostic presentation of Parkinson's disease in primary care: A case-control study

artículo científico publicado en 2015

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned

artículo científico publicado en 2016

Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

artículo científico publicado en 2006

Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)

scholarly article by Yuliya Stankevich et al published October 2018 in American Journal of Geriatric Psychiatry

Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD.

artículo científico publicado en 2015

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

artículo científico publicado en 2010

Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?

artículo científico

REM Sleep Behavioral Events and Dreaming

artículo científico publicado en 2015

REM sleep-associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations

artículo científico publicado en 2015

Rapid eye movement sleep behavioral events: a new marker for neurodegeneration in early Parkinson disease?

artículo científico publicado en 2014

Rare variants in LRRK1 and Parkinson's disease

artículo científico publicado en 2013

Rare variants in PLXNA4 and Parkinson's disease

artículo científico publicado en 2013

Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease

artículo científico publicado en 2015

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases

artículo científico publicado en 2010

Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson's disease

artículo científico publicado en 2015

SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder

artículo científico publicado en 2020

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

artículo científico publicado en 2007

Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study

artículo científico publicado en 2016

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

artículo científico publicado en 2005

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

artículo científico publicado en 2015

The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease

artículo científico publicado en 2016

The REM Sleep Behavior Disorder Screening Questionnaire is not Valid in De Novo Parkinson's Disease.

artículo científico publicado en 2018

The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease

artículo científico publicado en 2017

The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker

artículo científico publicado en 2017

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder

artículo científico

The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases

artículo científico publicado en 2011

The role ofSCARB2as susceptibility factor in Parkinson's disease

scholarly article by Franziska Hopfner et al published 13 February 2013 in Movement Disorders

The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature

artículo científico

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.

artículo científico publicado en 2006

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

artículo científico publicado en 2013

Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human α-Synuclein in cerebrospinal fluid.

artículo científico publicado en 2015

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

artículo científico publicado en 2015

Validation of conversion between mini-mental state examination and montreal cognitive assessment

artículo científico publicado en 2016

Validation of electrochemiluminescence assays for highly sensitive and reproducible quantification of α-synuclein in cerebrospinal fluid

artículo científico publicado en 2017

Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

artículo científico publicado en 2017

Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease

artículo científico publicado en 2012

What can biomarkers tell us about cognition in Parkinson's disease?

artículo científico

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

artículo científico publicado en 2011

α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system

artículo científico publicado en 2012

Lista de obras de Brit Mollenhauer

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal Fluid

A Practical Guide to Immunoassay Method Validation

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort.

Affective and cognitive Theory of Mind in patients with parkinson's disease

Age, drugs, or disease: what alters the macrostructure of sleep in Parkinson's disease?

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies

Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia

Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study

Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease

Associated factors for REM sleep behavior disorder in Parkinson disease

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease

Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease

Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype.

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Biobanking of CSF: international standardization to optimize biomarker development

Biochemical premotor biomarkers for Parkinson's disease

Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders

Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials

Biomarkers in biological fluids for dementia with Lewy bodies

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.

CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study

CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies

Can we prevent and slow down neurodegeneration with diet and exercise?

Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease

Cerebrospinal α-synuclein in α-synuclein aggregation disorders: tau/α-synuclein ratio as potential biomarker for dementia with Lewy bodies

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study

Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder

Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.

Erratum to: Different CSF β-amyloid processing in Alzheimer’s and Creutzfeldt–Jakob disease

Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach

Extracellular vesicle sorting of α-Synuclein is regulated by sumoylation

Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)

Fine-Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

GBA variants in REM sleep behavior disorder: a multicenter study

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)

Improved preparation of nasal lavage fluid (NLF) as a noninvasive sample for proteomic biomarker discovery

Increased CSF biomarkers of angiogenesis in Parkinson disease.

Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort.

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Metabolic profiling of body fluids and multivariate data analysis

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity